Aseptic Manufacturing and Sterile Fill Finish – An Ultimate Guide

Aseptic manufacturing is a method that involves sterilizing individual components of pharmaceutical products as needed before combining them. Following sterilization, the products are transferred to a controlled environment for the assembly of the product.

In this guide, we will explore all the critical aspects of aseptic manufacturing and sterile fill finish.

When do you Require a Sterile Fill Finish

The Sterile Fill-Finish process is utilized in parenteral drug production, securing patient well-being, upholding pharmacological effectiveness, and safeguarding product quality.

Therefore, for patient well-being, it is recommended by the FDA that drug items administered through these pathways are provided as sterile products.

Remember, there are two ways in which these drug products can be made sterile;

Terminal Sterilization

A method involving filling and sealing product containers in controlled conditions, then sterilizing the final product container through methods like heat or irradiation.

Aseptic Manufacturing and Sterile-fill Finish

A method involving individual sterilization of container, drug products and closure, followed by their assembly. Due to the absence of final container sterilization, precision in filling and sealing in a controlled environment is imperative (sterile fill-finish).

The FDA[Food and Drug Act] has consistently recommended manufacturers of ophthalmic, inhaled, parenteral, and otic drugs to utilize aseptic manufacturing and sterile fill-finish method if terminal sterilization is impractical.

Moreover, an increasing array of drug products and containers face challenges in terminal sterilization, as heat or radiation may lead to degradation or performance loss. Therefore, aseptic manufacturing and sterile finish emerge as ideal options for ensuring sterility.

Aseptic Manufacturing Overview
Aseptic Manufacturing Overview

What is Lyophilization in Aseptic Manufacturing?

This method, known as freeze-drying, removes water from drug products after freezing, enhancing the stability of formulations for sensitive or volatile parenteral drugs. It involves placing the product in a vacuum to eliminate air and excess water.

This method involves three stages which are interdependent and unique;

  1. Freezing process where products undergo freezing, causing the transformation of water into a solid state.
  2. Primary drying process which eliminates ice within the product through sublimation, transitioning from solid to vapor under reduced pressure but with increased temperature.
  3. Secondary drying process which involves elimination of remaining unfrozen water molecules through desorption. This is accomplished by increasing the temperature and further reducing pressure, completing the lyophilization process.

Normally, Lyophilization is needed for bulk drug ingredients that lack stability in either liquid or frozen states.


Examples of products suitable for lyophilization include:

  • Oligonucleotide
  • Peptides
  • Collagen
  • mAbs
  • Proteins
  • Enzymes
Lyophilization Process Flow Chart
Lyophilization Process Flow Chart

Benefits of Lyophilized Products

Some of the benefits possessed by Lyophilized products include;

  • Improving the stability of a powdered substance.
  • The product is kept at ambient temperature.
  • Extended product lifespan.
  • Ensures product safety for the customers
  • Disintegration of the reconstituted item.
  • Facilitate easier transportation of the products

Types of Sterile Processes

Sterile processing is mainly of two types, that is;

Terminal Sterilization

This method entails filling and sealing product containers in optimal conditions, then subjecting the final product in its container to sterilization through heat or irradiation.

Since terminal sterilization occurs after formulation and filling, it allows for more flexible and streamlined initial manufacturing processes. This minimizes complexity, boosts efficiency, and positively influences manufacturing costs, all while upholding quality standards.

Terminal sterilization
Terminal sterilization

Nevertheless, this approach may not be practical and could negatively impact both the product and its container. In cases where terminal sterilization is impractical, aseptic manufacturing stands out as the favored approach.

Aseptic Fill Finish

This method involves the individual sterilization of each component, including the drug, container, and closure. Subsequently, these sterilized components are combined within a dedicated Cleanroom with a highly controlled environment. This process ensures the creation of the final drug product in a contamination-free environment.

This strategy is prevalent across various pharmaceutical sectors, mostly in partnership with a Contract Development and Manufacturing Organization (CDMO). The CDMO usually assists in the sterile finishing development and manufacturing.

However, when choosing a collaborative CDMO, it’s essential to assess vital aspects and capabilities, including:

  1. Management approach
  2. Process validation methodology
  3. Production procedure
  4. Path to sustained continuous improvement
  5. Understanding your product

Ultimately, aseptic manufacturing aims to eliminate the possibility of contamination, protecting patients from harmful microorganisms or particles during administration.

An Overview of Aseptic Fill Finish
An Overview of Aseptic Fill Finish

Key Terminologies in Aseptic Manufacturing and Sterile Fill Finish

To understand aseptic manufacturing and sterile fill-finish, it’s essential to know key terms that describe the techniques and methods used during the process:


An apparatus employed for withdrawing or dispensing liquid in a slender stream and it consists of a plunger fitted tightly into a barrel. It is also used for wound or body cavity cleansing or equipped with a hollow needle for fluid injection or withdrawal.

You can learn more about robotic system for syringe filling machine.


This is a biological formulation developed to grant acquired immunity against a particular ailment. Vaccines typically contain a weakened or inactivated form of the disease-causing agent alongside its surface proteins or toxins. This triggers the immune system to recognize and neutralize the threat upon administration.

For instance, vial-filling machines play an important role here.


Vialis a compact vessel typically cylindrical and crafted from glass. They are employed mainly for the storage of liquid, capsules, or powdered medications and also serve as receptacles for scientific samples.


A cartridge syringe is a device that serves the purpose of administering anesthetic agents either subcutaneously or intramuscularly through injection. They are designed specifically for particular devices like autoinjectors and pre-filled syringes.


Parenteral drugs refer to medications given through pathways distinct from the digestive system. These drugs are administered using injection directly to the body system usually through three distinct routes: intravenous, subcutaneous, and intramuscular routes.


Injectable drugs are medications that are introduced into the bloodstream by the use of a syringe or a needle.


This is a medication or vaccine derived from living organisms, encompassing components like proteins, cells, sugars, DNA or living tissue. Potential sources include humans, animals, or microorganisms such as bacteria or viruses.

Additionally, biologic products like gene or protein therapy, can be employed to treat conditions like cancer or arthritis providing an effective alternative when conventional treatments prove insufficient.

Sterile Compounding

Entails the creation of medications in a setting devoid of viruses, bacteria or other potentially harmful microorganisms. This technique is employed for formulations intended for IV administration, injections, or direct application to the eyes.

In contrast, medications lacking sterility involve the creation of solutions, suspensions, ointments, creams, powders, suppositories, capsules, and tablets.

Recommended Aseptic Containers in Pharmaceutical Industry

Different kinds of aseptic container systems such as ampoules, syringes, cartridges and vials are tailored to uphold sterility throughout the aseptic manufacturing and sterile fill-finish processes.

These container systems are fashioned from either glass or plastic and include vials, syringes, bottles, cartridges, and ampoules.

Some of the vials, pre-filled syringes, and cartridges used in the aseptic manufacturing process include:

Cyclic Olefin Copolymer (COC)

This polymeric material possesses distinctive characteristics, including enhanced formability, chemical resistance, and transparency, making it suitable for preserving the integrity of valuable and intricate molecules.

Composite Material

A composite material comprised of a shaped, engineered polymer with an inert glass-like barrier coating system. The chemically resistant and contaminant-free inert glass-like barrier ensures a consistent surface, unaffected by the container’s shape or materials.

Borosilicate Glass

These containers are predominantly crafted from boron oxide and silica as their main glass-forming components. It is selected for its exceptional barrier properties, chemical durability, regulatory approval and adaptability in diverse applications.

Normally, before use, glass containers commonly go through pre-sterilization aimed at eliminating any foreign substance. The procedure involves multiple washes and rinses cycles using high-purity water. Following this, the containers are commonly exposed to dry heat to sterilize and remove any bacteria and endotoxins.

Plastic containers, due to their sensitivity to heat, are commonly sterilized using methods such as sterilizing gas or radiation with ethylene oxide [EtO] being an effective example commonly used.

Regulatory in Aseptic and Sterile Fill Finish


This is a regulatory guideline or standard set aside by the United States FDA and it stands for the Current Good Manufacturing Process. Its purpose is to offer directives for various systems to ensure correct planning, supervision, and regulation of processes and facilities in pharmaceutical manufacturing.

Note, that it is essential to consider some key aspects when manufacturing through an aseptic or Sterile fill finish, they include;

  • Ensure adequate filtration and circulation of air.
  • The process has been initiated and documented.
  • Ensure employees receive proper training, wear suitable attire and are under supervision.
  • Ensure appropriate separation and categorization of your clean space.
  • Containers and closures are subjected to proper sterilization and upkeep measures.
  • Precise time constraints are set and strictly followed for processes like sterilization, filtration, or bulk processing.

Therefore, compliance with GMP regulations guarantees the proper production of drug products by a manufacturer or CDMO. It instills confidence in patients regarding the accurate identity, strength and purity of medications.

· Parental Drug Association

The association was established in 1997 with the goal of bridging the gap between people, science, and regulation. PDA also played a key role in establishing the PDA Foundation [PDAF], with goals that include;

  • Enhance public awareness and educate communities on the field of pharmaceutical sciences.
  • Assist in advancing the educational, training, and research efforts led by the Parenteral Drug Association.
  • Foster educational initiatives, provide training and facilitate research in the field of pharmaceutical sciences.

International Association of Pharmaceutical Engineering [ISPE]

ISPE is the largest nonprofit organization globally, dedicated to guiding its members through scientific, technical, and regulatory progress across the entire pharmaceutical lifecycle. It plays a crucial role in driving innovation in manufacturing and supply chains, ensuring the supply of high-quality medicines through operational excellence and regulatory insights.

Consideration for Aseptic Processing and Sterile Finish

Personnel Training

Individuals engaged in aseptic procedures must receive thorough training in aseptic conduct and Cleanroom protocols. This is essential to reduce the potential for contamination caused by human factors.

As per FDA guidelines, personnel represent a significant potential source of contamination. Therefore, an effective training program at the very least, should cover the following:

  • Hygiene
  • Microbiology
  • Aseptic techniques
  • Cleanroom behavior
  • Patient safety hazards posed by non-sterile drug products
  • Specific written procedures covering aseptic manufacturing area operations
  • Gowning

Continuous training and assessments of both Cleanroom personnel and procedures are crucial to safeguard products from potential contamination risks. Similar principles apply to laboratory staff conducting aseptic sample testing and generating microbiological data from Cleanroom, as they must also prevent sample contamination.

Container System

Aseptic processing and sterile fill-finish operations apply to various container systems, crafted from either glass or plastic. These systems include vials, syringes, bottles, cartridges, and ampoules.

Normally, before use, glass containers commonly go through pre-sterilization aimed at eliminating any foreign substance. The procedure involves multiple wash and rinse cycles using high-purity water. Subsequently, the containers are commonly exposed to dry heat to sterilize and remove any bacteria as well as endotoxins.

Plastic containers, given their sensitivity to heat, are commonly sterilized using methods such as sterilizing gas or radiation with ethylene oxide [EtO] being an effective example commonly used.

Remember to carefully monitor and maintain the residual levels of sterilizing agents within the specified regulatory thresholds especially when ethylene oxide is in use.

Cleanroom Design

A cleanroom is a regulated environment that oversees aspects such as personnel access, contamination levels, pressurization, and humidity or temperature. The cleanroom suite includes several rooms with different levels of control, a configuration often referred to as a ‘cascading’ design.

In Cleanrooms tailored for aseptic processing and sterile fill-finish activities, the design is intentionally structured to streamline the movement of materials, personnel, and equipment during manufacturing. The initiation of personnel, materials, and equipment mobilization occurs within specific zones dedicated to tasks like non-sterile preparation, gowning, and formulation.

The Critical Area upholds the utmost air quality standards. Here are the methods that can be utilized to identify microorganisms:

  • Passive air monitoring
  • Active monitoring
  • Non-viable particulate monitoring
  • Non-viable particulate monitoring
  • Personnel monitoring
  • Surface monitoring
Update cookies preferences
Scroll to Top

Get a Quick Quote!